A retrospective cohort study of real-world clinical outcomes in patients with CLL/SLL previously treated with covalent BTK inhibitor (cBTKi) and BCL2 inhibitor (BCL2i) regimens.

Authors: Jennifer Prescott, Christina Parrinello, Ahmed Sawas, Enrico De Nigris, Jing Yang, Erik Bloomquist, Indu Shrivastava, Changxia Shao, Xinyue Liu, Mohammed Zulfiqar Husain Farooqui, Sameer Ashok Parikh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19025

Source: Full article

---

Abstract

e19025